Acadia Pharmaceuticals | ACAD - 普通股股本

金融业

USD

USD 1.56B

现金及等价物

USD 819.69M

USD 26.23M

USD 1.06B

USD 277.11M

USD 54.81M

USD 17.39M

USD 35.76M

653

EPS每股收益

USD 1.6

股本和储备

USD 917.27M

USD 257.76M

债务利息支出

USD 0

USD 8.25M

USD 0

USD 3.76B

USD 273.57M

USD 266.6M

USD 17.39M

普通股股本

USD 169.18M

11.61

USD 26.32M

USD 284M

销售和管理费用

USD 146.73M

USD 34.67M

贸易债权人

USD 10.9M

应收帐款人

USD 148.23M

	普通股股本	更改		日
Acadia Pharmaceuticals	USD 169.18M		470K	2025-12
ALKERMES	USD 165.61M		503K	2025-12
Alnylam Pharmaceuticals	USD 132.38M		585K	2025-12
Biogen	USD 146.7M		200K	2025-09
BioMarin Pharmaceutical	USD 192.3M		201K	2025-12
Bristol-Myers Squibb	USD 2.04B		1.74B	2025-09
Cara Therapeutics	USD 9.38M		9.38M	2025-09
Corcept Therapeutics	USD 105.97M		842K	2025-12
Cytokinetics	USD 122.26M		145K	2025-12
Eisai	JPY 282.11M		1000	2025-12
Eli Lilly	USD 946.83M		354.23M	2025-06
Incyte	USD 198.46M		2.33M	2025-12
J&J	USD 2.41B		584K	2025-09
Moderna	USD 391M		2M	2025-09
Neurocrine Biosciences	USD 100.1M		400K	2025-12
Pfizer	USD 5.69B		1000K	2025-09
Prothena	USD 53.83M		3K	2025-12
PTC Therapeutics	USD 81.47M		1.54M	2025-12
Sarepta Therapeutics	USD 104.96M		196K	2025-12
Ultragenyx Pharmaceutical	USD 96.44M		88K	2025-09
Vanda Pharmaceuticals	USD 58K		0	2024-12
Vertex Pharmaceuticals	USD 254M		0	2025-12